Clovis Oncology (CLVS) Gains Again Amid Continued Takeover Chatter

September 22, 2016 10:42 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Rumored takeover target Clovis Oncology (NASDAQ: CLVS) is gaining again. Shares are up 5.5%. Shares are up 189% over the last 3 months, up 109% over the last month and up 23% over the last 5 days.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment